GSK 221458
This app is specifically intended for participants in the GSK 221458 study only
About GSK 221458
This app is specifically intended for participants in the GSK 221458 study only.
It contains Televisit functionality and allows participants to complete questionnaires.
The study is a Phase 1, first-time-in-human, three-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active systemic lupus erythematosus (Part B), and healthy participants of Chinese and Japanese descent (Part C).
(Televisit tasks are not enabled by default and may be enabled as needed, by study officials.)
Similar Apps
Medable
Medable is on a mission to enable effective therapies to people faster....
J1I-MC-GZQD
This app has been exclusively created for participants in the medical study...
Avanti
For invited Avanti study participants. You will use this app to consent...
GSK 219685
This app has been created exclusively for participants in the medical study...
GSK 219855 France
You are invited to participate in the GSK BLISSc-ILD OLE study. This...
J3M-MC-JZQH
This app has been exclusively created for participants with Resected or Unresectable...
